Incidence, timing and risk factors associated with 1-year mortality after hospitalization for community-acquired pneumonia
Introduction
Community-acquired pneumonia (CAP) is one of the main public health problems worldwide.1 In industrialized countries, CAP is a major cause of death and the most frequent cause of mortality among infectious diseases.2
Recent studies have found overall in-hospital mortality rates of 8%–15%.3, 4 Importantly, it has been shown that hospitalization for this infection is associated with high long-term mortality compared with other major medical conditions.5 The frequency of long-term mortality reported in these studies ranged from 11% to 53%.5, 6, 7, 8, 9 The increase in long-term mortality appears to be related to several aspects, mainly chronic comorbid conditions.5, 7 However, the prognostic factors associated with 1-year mortality after an episode of CAP are not well known.10 Notably, information about causes of 1-year mortality is also scarce and data on the timing of death are lacking.
Therefore, there is a significant interest in gaining further insight into the relationship between CAP and 1-year mortality for patients who survive to the initial acute event. A better understanding of factors related with this complication in patients with CAP may have implications for patient care. Therefore, this is an important issue that requires comprehensive evaluation.11
This study of a large prospective cohort of hospitalized adult patients with CAP aimed to identify the incidence, causes, timing and risk factors associated with 1-year mortality after hospital discharge.
Section snippets
Setting and study design
The observational study was carried out in a 700-bed university hospital for adults in Barcelona, Spain that serves an area of 1.1 million inhabitants and admits approximately 24,000 patients per year. All adult patients >17 years of age with CAP who were admitted to the hospital from 1 January 2007 to 31 December 2011 were prospectively recruited and followed up. Patients with neutropenia, immunoglobulin deficiencies, HIV infection, transplantation or splenectomy, as well as those who were
Results
During the study period, 1405 non-immunosuppressed adults with CAP were hospitalized. Two hundred and fourteen (15.2%) patients died during the 1-year follow-up, of whom 121 died during hospitalization. Of the 1284 patients discharged from the hospital, 93 (7.2%) died within 1-year of leaving hospital.
Discussion
In this prospective study of a large cohort of hospitalized patients with CAP, we found that a considerable number of patients died within 1-year after discharge, mainly in the first six months. The major causes of mortality were infectious diseases or acute cardiovascular events. The risk factors independently associated with 1-year mortality after hospital discharge were comorbidity conditions, rehospitalization within 30 days of hospital discharge and nursing home residence.
In the present
Funding
This work was supported by the Fondo de Investigación Sanitaria de la Seguridad Social (grant 11/01106) and Spain's Ministerio de Economía y Competitividad, Instituto de Salud Carlos III, co-financed by the European Regional Development Fund “A way to achieve Europe” ERDF and the Spanish Network for Research in Infectious Diseases (REIPI RD12/0015). Dr. Viasus is the recipient of a research grant from the REIPI. Dr. Garcia-Vidal is the recipient of a Juan de la Cierva research grant from the
Contributorship
All investigators had given final approval of the submitted manuscript.
Study concept and design: Adamuz, Viasus, Garcia-Vidal, Isla, Dorca, and Carratalà.
Acquisition of data: Adamuz, Viasus, Jiménez Martínez, and Garcia-Vidal.
Analysis and interpretation: Adamuz, Viasus and Carratalà.
Drafting the manuscript: Adamuz, Viasus, and Carratalà.
Critical revision of the manuscript for important intellectual content: Jiménez Martínez, Garcia-Vidal, Isla and Dorca.
Study supervision: Viasus, Carratalà and
Conflict of interest statement
None of the authors have conflicts of interest to disclose.
References (23)
- et al.
Cause-specific long-term mortality rates in patients recovered from community-acquired pneumonia as compared with the general Dutch population
Clin Microbiol Infect
(2011) - et al.
Aetiology of, and risk factors for, recurrent community-acquired pneumonia
Clin Microbiol Infect
(2009) - et al.
Infectious Disease Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults
Clin Infect Dis
(2007) - et al.
Deaths: final data for 2006
Natl Vital Stat Rep
(2009) - et al.
Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis
JAMA
(1996) - et al.
Etiology, reasons for hospitalization, risk classes, and outcomes of community-acquired pneumonia in patients hospitalized on the basis of conventional admission criteria
Clin Infect Dis
(2001) - et al.
Long-term mortality after pneumonia
Semin Respir Crit Care Med
(2012) - et al.
Long-term morbidity and mortality after hospitalization with community-acquired pneumonia: a population-based cohort study
Medicine (Baltimore)
(2008) - et al.
Influence of comorbid conditions on long-term mortality after pneumonia in older people
J Am Geriatr Soc
(2007) - et al.
Assessment of mortality after long-term follow-up of patients with community-acquired pneumonia
Clin Infect Dis
(2003)
Community-acquired pneumonia as an emergency: time for an aggressive intervention to lower mortality
Eur Respir J
Cited by (36)
American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update
2022, Endocrine PracticeCitation Excerpt :A cohort study of adults <65 years of age with DM showed that DM increased the risk of influenza-associated hospitalizations by 6% (risk ratio, 1.06; 95% CI, 1.02-1.10; absolute risk difference 6 per 1000 adults per year), even though the rates of influenza and pneumonia were similar between diabetic and nondiabetic populations (P = .11).1825 Both community-acquired and nosocomial infections with pneumococcal bacteria may also be higher among persons with DM, who may also be at greater risk of death from these diseases.1826-1828 However, vaccines can safely and effectively reduce serious complications from influenza.
Disability, and not diabetes, is a strong predictor of mortality in oldest old patients hospitalized with pneumonia
2018, European Journal of Internal MedicineCitation Excerpt :In our elderly inpatients there was no association between diabetes and mortality, in agreement with us a large Danish population study shown no increase in mortality among diabetic people with different causes of pneumonia [29]. On the other hand our results are in contrast with recent observational studies that showed that hospitalization for pneumonia is associated with a reduction of one-year survival in diabetic patients [8]. A possible explanation might be that we have considered the age-related complexities using different clinical characteristics, choosing to insert in our model different variables such as the Short Blessed Test, the Severity Index, the Polytherapy, the Barthel Index that were not globally analyzed in other studies.
Risk of pneumonia associated with incident benzodiazepine use among communitydwelling adults with Alzheimer disease
2017, CMAJCitation Excerpt :Benzodiazepines and Z-drugs are frequently prescribed for this population, and long-term use is typical.8,30 Pneumonia often leads to admission to hospital,10 and patients with dementia are at increased risk of death related to pneumonia.12,13 Although our findings need further research and confirmation, the increased risk of pneumonia should be considered when benzodiazepines and Z-drugs are prescribed to older adults with Alzheimer disease.
Long-Term Outcomes in Severe Community-Acquired Pneumonia
2024, Seminars in Respiratory and Critical Care Medicine